The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 1-Germany seeks to extend AstraZeneca jabs to over 65s soon

Wed, 03rd Mar 2021 08:36

(Adds details, background)

BERLIN, March 3 (Reuters) - Germany's vaccine regulator
should recommend within days that the AstraZeneca
coronavirus vaccine can be given to people older than 65 as
evidence mounts of its efficacy, Health Minister Jens Spahn said
on Wednesday.

Data from Britain show that the jab works "very well" in
older people, Spahn told German television, adding that he had
asked the regulator to adjust its recommendation accordingly so
the vaccine can be rolled out quickly to those over 65.

"If we could vaccinate the over-65-year-olds with
AstraZeneca, that would really speed things up and protect the
most vulnerable more quickly," he said.

The German policy that the AstraZeneca vaccine be given only
to people aged 18 to 64 has led to a low take-up of available
doses, slowing vaccination efforts, prompting the government
last week to urge the public to accept the jabs.

On Tuesday, the French health minister said the country will
allow people under 75 with existing health problems to get the
AstraZeneca vaccine, departing from an earlier stance that the
vaccine should be for the under-65s only.

The reassessment is likely to help speed up France's
vaccination campaign which many have criticized as too slow.

Britain has been rolling out the AstraZeneca vaccine since
January, beginning with the elderly and health workers, after
approving its use for all adults.

Spahn is also in favour of adopting the British practice of
extending the time between the first and second jabs so that
more people can be protected quickly, both for the AstraZeneca
vaccine and that made by Pfizer/BioNTech.
(Reporting by Emma Thomasson
Editing by Riham Riham Alkousaa and Madeline Chambers)

Related Shares

More News
3 Jul 2024 09:57

Aptamer shares jump as inks agreement with AstraZeneca

(Alliance News) - Aptamer Group PLC on Wednesday said it reached an agreement with AstraZeneca PLC.

2 Jul 2024 09:47

LONDON BROKER RATINGS: Deutsche Bank cuts Quilter, ups Polar Capital

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

1 Jul 2024 09:13

TOP NEWS: AstraZeneca cancer and Covid drugs recommended for approval

(Alliance News) - AstraZeneca PLC on Monday said two cancer treatments had been recommended for approval in the European Union, while there was also p...

1 Jul 2024 07:41

LONDON BRIEFING: Stocks called higher ahead of Thursday's election

(Alliance News) - Stocks in London are called to open higher on Monday, at the start of a politically fuelled week.

1 Jul 2024 07:17

AstraZeneca endometrial cancer treatment recommended for EU approval

(Sharecast News) - AstraZeneca announced on Monday that 'Imfinzi', or durvalumab, and 'Lynparza', or olaparib, have received a recommendation for appr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.